189 related articles for article (PubMed ID: 12354380)
1. The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching.
Jabara H; Laouini D; Tsitsikov E; Mizoguchi E; Bhan A; Castigli E; Dedeoglu F; Pivniouk V; Brodeur S; Geha R
Immunity; 2002 Sep; 17(3):265-76. PubMed ID: 12354380
[TBL] [Abstract][Full Text] [Related]
2. TRAF2 and TRAF3 independently mediate Ig class switching driven by CD40.
Jabara HH; Weng Y; Sannikova T; Geha RS
Int Immunol; 2009 Apr; 21(4):477-88. PubMed ID: 19228877
[TBL] [Abstract][Full Text] [Related]
3. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
[TBL] [Abstract][Full Text] [Related]
4. TRAF2 Deficiency in B Cells Impairs CD40-Induced Isotype Switching That Can Be Rescued by Restoring NF-κB1 Activation.
Woolaver RA; Wang X; Dollin Y; Xie P; Wang JH; Chen Z
J Immunol; 2018 Dec; 201(11):3421-3430. PubMed ID: 30341187
[TBL] [Abstract][Full Text] [Related]
5. Dissection of B cell differentiation during primary immune responses in mice with altered CD40 signals.
Yasui T; Muraoka M; Takaoka-Shichijo Y; Ishida I; Takegahara N; Uchida J; Kumanogoh A; Suematsu S; Suzuki M; Kikutani H
Int Immunol; 2002 Mar; 14(3):319-29. PubMed ID: 11867568
[TBL] [Abstract][Full Text] [Related]
6. Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40.
Tsukamoto N; Kobayashi N; Azuma S; Yamamoto T; Inoue J
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1234-9. PubMed ID: 9990007
[TBL] [Abstract][Full Text] [Related]
7. Specificities of CD40 signaling: involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up-regulation.
Lee HH; Dempsey PW; Parks TP; Zhu X; Baltimore D; Cheng G
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1421-6. PubMed ID: 9990039
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions.
Jalukar SV; Hostager BS; Bishop GA
J Immunol; 2000 Jan; 164(2):623-30. PubMed ID: 10623803
[TBL] [Abstract][Full Text] [Related]
9. Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo.
Lumsden JM; Williams JA; Hodes RJ
J Immunol; 2003 Jan; 170(2):781-7. PubMed ID: 12517941
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling.
Hostager BS; Haxhinasto SA; Rowland SL; Bishop GA
J Biol Chem; 2003 Nov; 278(46):45382-90. PubMed ID: 12958312
[TBL] [Abstract][Full Text] [Related]
11. CD40-mediated activation of Ig-Cgamma1- and Ig-cepsilon germ-line promoters involves multiple TRAF family proteins.
Leo E; Zapata JM; Reed JC
Eur J Immunol; 1999 Dec; 29(12):3908-13. PubMed ID: 10601998
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation.
Hostager BS; Bishop GA
J Immunol; 1999 Jun; 162(11):6307-11. PubMed ID: 10352240
[TBL] [Abstract][Full Text] [Related]
13. Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent.
Manning E; Pullen SS; Souza DJ; Kehry M; Noelle RJ
Eur J Immunol; 2002 Jan; 32(1):39-49. PubMed ID: 11754002
[TBL] [Abstract][Full Text] [Related]
14. TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation.
He L; Grammer AC; Wu X; Lipsky PE
J Biol Chem; 2004 Dec; 279(53):55855-65. PubMed ID: 15383523
[TBL] [Abstract][Full Text] [Related]
15. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
[TBL] [Abstract][Full Text] [Related]
16. Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1.
Graham JP; Moore CR; Bishop GA
J Immunol; 2009 Sep; 183(5):2966-73. PubMed ID: 19667091
[TBL] [Abstract][Full Text] [Related]
17. A novel interaction between protein kinase D and TNF receptor-associated factor molecules regulates B cell receptor-CD40 synergy.
Haxhinasto SA; Bishop GA
J Immunol; 2003 Nov; 171(9):4655-62. PubMed ID: 14568940
[TBL] [Abstract][Full Text] [Related]
18. The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation.
Lu LF; Ahonen CL; Lind EF; Raman VS; Cook WJ; Lin LL; Noelle RJ
Blood; 2007 Jul; 110(1):193-200. PubMed ID: 17360936
[TBL] [Abstract][Full Text] [Related]
19. Impaired CD40-signalling in CD19-deficient mice selectively affects Th2-dependent isotype switching.
Gärdby E; Chen XJ; Lycke NY
Scand J Immunol; 2001 Jan; 53(1):13-23. PubMed ID: 11169202
[TBL] [Abstract][Full Text] [Related]
20. A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling.
Rowland SL; Tremblay MM; Ellison JM; Stunz LL; Bishop GA; Hostager BS
J Immunol; 2007 Oct; 179(7):4645-53. PubMed ID: 17878362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
